ICAAC 2013
The 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013), was held in Denver, USA, 10-13th September 2013.
-
10-13 September 2013
-
Denver, USA
Liver cancer often diagnosed late with poor survival in people with HIV
New integrase inhibitor GSK1265744 safe and well tolerated in eight studies
Is HCV infection spreading among HIV-positive gay men in Japan?
Stribild is effective and well tolerated in older people with HIV
Tenofovir vaginal ring protects monkeys on Depo-Provera against HIV-like virus
Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people
Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation
HPV type 39 linked to anal dysplasia, better screening needed for HIV+ men and women
Switching from Atripla to Eviplera reduces central nervous system side-effects
Interferon response reduces liver disease and death in HIV/HCV co-infected people
Raltegravir appears safe for mothers and babies during pregnancy
Depression linked to episodes of detectable HIV in cerebrospinal fluid
Novel NNRTI AIC292 works well against drug-resistant HIV
New NNRTI MK-1439 interacts with ritonavir but not tenofovir
Dolutegravir shows good efficacy across broad range of patient groups
US PrEP prescriptions more likely to go to Southern women
New tenofovir formulation works equally well with less effect on kidneys and bones